Indianapolis, IN, United States of America

Robert Bacallao

This inventor holds 6 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignees: Indiana University, The United States Government as Represented by the Department of Veterans Affairs. Active years: 2007-2025.

USPTO Granted Patents = 6 

% Patents Active = 83.3

 

 

Average Co-Inventor Count = 2.2

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2007-2025

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Robert Bacallao

Introduction

Robert Bacallao is a notable inventor based in Indianapolis, IN (US), recognized for his significant contributions to the field of gene therapy. With a total of 6 patents to his name, Bacallao has focused on developing methods that enhance the delivery of gene therapy treatments, particularly in relation to kidney health.

Latest Patents

Bacallao's latest patents include innovative methods for the delivery of gene therapy treatments. One of his key inventions provides methods and materials useful for delivering liquids, including those comprising nucleic acid molecules into cells. Specifically, this invention outlines techniques for delivering saline solutions, exogenous compositions, and isolated vectors to kidney cells, utilizing the renal vein as a guide and applying hydrodynamic pressure. These delivery methods and materials are instrumental in researching, prognosing, ameliorating symptoms of kidney injury, and treating various kidney pathologies.

Career Highlights

Throughout his career, Bacallao has worked with esteemed organizations such as Indiana University and the United States Government, as represented by the Department of Veterans Affairs. His work in these institutions has allowed him to advance his research and contribute to the field of medical science significantly.

Collaborations

Bacallao has collaborated with notable colleagues, including Simon Atkinson and George J. Rhodes. These partnerships have fostered an environment of innovation and have led to the development of groundbreaking technologies in gene therapy.

Conclusion

Robert Bacallao's work exemplifies the spirit of innovation in the field of gene therapy. His contributions are paving the way for advancements in treating kidney-related health issues, showcasing the importance of research and collaboration in scientific progress.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…